Table 3. Bifurcation-related endpoints.

		Provisional (n=103)	Culotte (n=97)	Hazard ratio (95% CI)	p-value
Bifurcation-related adverse cardiac events (BACE)
Bifurcation-related acute vessel closure, stent thrombosis (probable or definite), Type 1 MI or revascularisation.		6 (5.8)	7 (7.2)	0.80 (0.27-2.39)	0.69
Individual endpoints
Periprocedural	Acute vessel closure	1 (1.0)	1 (1.0)	0.95 (0.06-15.13)	0.97
Stent thrombosis	Definite/probable	1 (1.0)	2 (2.1)	0.47 (0.04-5.16)	0.54
Myocardial infarction	Type 1 MI	0 (0)	1 (1.0)	0.02 (0->100)	0.61
Clinically significant restenosis	Target lesion revascularisation	4 (3.9)	3 (3.1)	1.28 (0.29-5.73)	0.75
Site of bifurcation failure
Main vessel		1 (1.0)	2 (2.1)	p=ns
Side branch		3 (2.9)	2 (2.1)
Both		1 (1.0)	1 (1.0)
Values are n (%). CI: confidence interval; MI: myocardial infarction; ns: non-significant